US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESG Concept

2,793.84

+31.251.13%

Number of Gainers:33

Number of Losers:11

Number of Flat:- -

PE:- -

High:2,826.88

Open:2,761.75

Low:2,761.75

Close:2,762.60

Loading ...

Vertex Pharmaceuticals Inc - Working With Nice and Nhs for Alyftrek Access

THOMSON REUTERS

Vertex Announces UK Mhra Approval of Alyftrek® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class Cftr Modulator for the Treatment of Cystic Fibrosis

THOMSON REUTERS

Do Its Financials Have Any Role To Play In Driving Fastenal Company's (NASDAQ:FAST) Stock Up Recently?

Simply Wall St.

THE MEXICO FUND, INC. DECLARES DISTRIBUTION

COTY Stock Plunges More Than 25% in 3 Months: What Should You Do?

Is the Options Market Predicting a Spike in Applied Materials (AMAT) Stock?

Is it Worth Adding ResMed Stock to Your Portfolio Now?

InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

Vertex Pharmaceuticals' Triple Combination Cystic Fibrosis Therapy Alyftrek Receives Approval in UK

MT Newswires Live

Analysts Have Conflicting Sentiments on These Industrial Goods Companies: GFL Environmental (GFL), Joby Aviation (JOBY) and Fastenal Company (FAST)

BRIEF-UK's MHRA Approves Triple Combination Of Deutivacaftor/Tezacaftor/Vanzacaftor For Cystic Fibrosis

UK's Mhra Says Triple Combination Medicine Deutivacaftor/Tezacaftor/Vanzacaftor Approved for Cystic Fibrosis

THOMSON REUTERS

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

It's retailers' turn to be 'resilient': Morning Brief

Elia Group Announces EUR 2.2 Bln Equity Package

Agilent’s Strategic Positioning in the Lp(a) Market: A Compelling Buy Recommendation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4567/news?page=35"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4567","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4567\",,,,,undefined,":{"symbol":"BK4567","market":"US","secType":"PLATE","nameCN":"ESG Concept","latestPrice":2793.8425,"timestamp":1742414399999,"preClose":2762.5964,"halted":0,"volume":388775225,"delay":0,"changeRate":0.01131,"change":31.246094,"pbRate":10.777969,"amount":56993291352.90881,"amplitude":0.023576,"prevYearClose":3061.5488,"fiveDayClose":2768.238,"twentyDayClose":3094.8826,"turnoverRate":0.008613,"marketCap":8653319063504,"floatMarketCap":8506472442568,"peRate":32.585371},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4567\",,,,,undefined,":{"symbol":"BK4567","high":2826.8757,"amplitude":0.023576,"preClose":2762.5964,"low":2761.746,"pbRate":"10.777969","latestPrice":2793.8425,"volume":388775225,"delay":0,"open":2761.746,"prevYearClose":3061.5488,"prevWeekClose":2820.2246,"prevMonthClose":2921.397,"prevQuarterClose":3061.5488,"fiveDayClose":2768.238,"twentyDayClose":3094.8826,"sixtyDayClose":3065.898,"secType":"PLATE","market":"US","turnoverRate":0.008613,"peRate":32.585371,"marketCap":8653319063504,"floatMarketCap":8506472442568,"timestamp":1742414399999,"nameCN":"ESG Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4567\",,,,undefined,":{"bkCode":"BK4567","up":33,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4567\",pageSize:16,pageCount:35,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517431273","title":"Vertex Pharmaceuticals Inc - Working With Nice and Nhs for Alyftrek Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2517431273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517431273?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:02","pubTimestamp":1741359720,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA7VCKSK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0061475181.USD","LU0109394709.USD","LU1093756325.SGD","LU2236285917.USD","BK4533","BK4139","LU2456880835.USD","BK4567","IE0002141913.USD","LU1093756168.USD","LU2362540622.SGD","LU1069344957.HKD","LU2462157665.USD","LU2362541513.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4585","LU1585245621.USD","LU1035775433.USD","LU2417539215.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU0058720904.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","LU2237438978.USD","LU0079474960.USD","LU2324357040.USD","BK4588","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU0320765992.SGD","VRTX","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU2362541273.HKD","IE0009355771.USD","LU0417517546.SGD","LU1430594728.SGD","LU0256863811.USD","LU0889565916.HKD","BK4532"],"gpt_icon":0},{"id":"2517312774","title":"Vertex Announces UK Mhra Approval of Alyftrek® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class Cftr Modulator for the Treatment of Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517312774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517312774?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:02","pubTimestamp":1741359720,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA7VCKSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","BK4139","LU1069344957.HKD","LU2417539215.USD","LU0058720904.USD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU1093756168.USD","IE00B894F039.SGD","VRTX","LU0061475181.USD","IE00B19Z9Z06.USD","BK4567","LU2236285917.USD","LU2324357040.USD","LU2362541513.USD","IE00B19Z9P08.USD","LU0889565916.HKD","LU2237438978.USD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU1093756325.SGD","IE00B19Z3581.USD","BK4533","LU0256863811.USD","LU0079474960.USD","LU0823416689.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","BK4588","LU0234570918.USD","LU1035775433.USD","LU2456880835.USD","LU2462157665.USD","BK4532","IE00B2B36J28.USD","LU0320765992.SGD","LU2362541273.HKD","LU0289739699.SGD","LU0109394709.USD","IE0002141913.USD","LU1585245621.USD","IE0009355771.USD","LU0417517546.SGD","BK4585","LU2362540622.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2517439235","title":"Do Its Financials Have Any Role To Play In Driving Fastenal Company's (NASDAQ:FAST) Stock Up Recently?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517439235","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517439235?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:00","pubTimestamp":1741356009,"startTime":"0","endTime":"0","summary":"Fastenal's  stock is up by a considerable 5.9% over the past month. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. In this article, we decided to focus on Fastenal's  ROE.Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.Return on Equity = Net Profit  ÷ Shareholders' Equity. So, based on the above formula, the ROE for Fastenal is:. While Fastenal has a three-year median payout ratio of 68% , the company has still seen a fair bit of ear","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/financials-role-play-driving-fastenal-140009184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","LU2210150020.SGD","PSQ","LU2210149790.SGD","USAW.SI","USJW.SI","BK4104","IE00BFXG0V08.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","BK4567","QLD","IE00BKPKM429.USD","TQQQ","MNQmain","IE00B5TLWC47.USD","SQQQ","NVIW.SI","TSYW.SI","NDAQ","BK4112","NQmain","QID","IE00BYQQ9H92.USD","BK4585","BK4588","IE00B3QW5Z07.USD","FAST"],"gpt_icon":1},{"id":"2517351644","title":"THE MEXICO FUND, INC. DECLARES DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2517351644","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517351644?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:00","pubTimestamp":1741356000,"startTime":"0","endTime":"0","summary":"COLUMBIA, Md., March 7, 2025 /PRNewswire/ -- The Mexico Fund, Inc. , announced that the Board of Directors  declared a distribution of $0.22 per share to stockholders of record on April 22, 2025, which is payable in cash on April 30, 2025.The Board has approved the continuation of the Fund's MDP during 2025. The Board may amend or terminate the MDP at any time without prior notice to stockholders. Since the implementation of the MDP in September 2008, the Fund has paid a total of $27.26 per share in cash distributions to stockholders.The amount of distributable income for each fiscal period depends on the aggregate gains and losses realized by the Fund during the entire year. Distributions may consist of net investment income, capital gains and return of capital, but the character of these distributions cannot be determined until after the end of the Fund's fiscal year. However, under the Investment Company Act of 1940, the Fund is required to indicate the source of each distribution t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/mexico-fund-inc-declares-distribution-140000450.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mexico-fund-inc-declares-distribution-140000450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["A","FUND","LU2041044095.USD","IE00BN0W2W23.USD","INC","LU2413666426.HKD","BK4121","BK4567","LU2092937221.SGD","IE00BN0W2T93.GBP","BK4585","LU1721428933.USD","LU1543694498.USD","LU0347712357.USD","LU1165135440.EUR","LU2413666699.HKD","MXF","BK4588","IE00BN0W2V16.EUR"],"gpt_icon":0},{"id":"2517455692","title":"COTY Stock Plunges More Than 25% in 3 Months: What Should You Do?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517455692","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517455692?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:31","pubTimestamp":1741354260,"startTime":"0","endTime":"0","summary":"Coty Inc. COTY, a major player in the beauty industry, is grappling with rising costs and weaker-than-expected demand, especially in its key markets like China, Travel Retail Asia and the United States. During the second quarter of fiscal 2025, the company saw a decline in both top and bottom-line results and also missed the Zacks Consensus Estimate. Despite strong holiday sales in core markets, Coty couldn't capitalize on the momentum as retailers maintained tight inventory control, impacting sales growth.Such challenges have led to a notable 25.7% drop in its share price in the past three months. The stock underperformed the industry, the broader Zacks Consumer Staples sector and the S&P 500 in the said time frame. While the industry and the S&P 500 declined 21.4% and 3.3%, respectively, the sector rose 1.5%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coty-stock-plunges-more-25-133100767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3581.USD","BK4567","DECK","BK4146","IE0002270589.USD","LFL","ULTA","BK4585","NUS","IE00B19Z3B42.SGD","BK4588","BK4183","IE00B7SZLL34.SGD","COTY","LU0266013472.USD","LU0823411888.USD","BK4532","BK4200"],"gpt_icon":0},{"id":"2517437400","title":"Is the Options Market Predicting a Spike in Applied Materials (AMAT) Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517437400","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517437400?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:30","pubTimestamp":1741354200,"startTime":"0","endTime":"0","summary":"Investors in Applied Materials, Inc. AMAT need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 21, 2025 $90 Call had some of the highest implied volatility of all equity options today.Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.Clearly, options traders are pricing in a big move for Applied Materials shares, but what is the fundamental picture for the company?Applied Materials, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/options-market-predicting-spike-applied-133000182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4516","LU0109392836.USD","LU0354030438.USD","SG9999001424.SGD","LU2028103732.USD","LU1267930813.SGD","LU1674673428.USD","BK4518","BK4519","LU2023250504.SGD","LU0792757196.USD","LU0444973449.USD","BK4534","LU2023250843.SGD","BK4588","LU0061474960.USD","LU0868494617.USD","LU0942090050.USD","BK4544","LU1815333072.USD","LU1153585028.USD","LU0476273544.USD","BK4567","LU2106854487.HKD","LU2111349929.HKD","LU0957791311.USD","LU0158827948.USD","LU2458330243.SGD","SG9999002232.USD","BK4585","LU1974910355.USD","ARKG","IE00BQXX3C00.GBP","LU0354030511.USD","LU1046421795.USD","LU1674673691.USD","LU1815336760.USD","LU1989773731.SGD","LU1778281490.HKD","LU2271345857.HKD","BK4543","LU0957808578.USD","LU0348723411.USD","LU2089284900.SGD","LU1917777945.USD","AMAT","BK4533","LU1989763005.USD","IE00B5949003.HKD","LU2089283258.USD"],"gpt_icon":0},{"id":"2517362604","title":"Is it Worth Adding ResMed Stock to Your Portfolio Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517362604","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517362604?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:11","pubTimestamp":1741353060,"startTime":"0","endTime":"0","summary":"ResMed Inc.’s RMD growth in the second quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth. The company’s SaaS business growth is driven by strategic buyouts. However, the increasing debt burden on ResMed’s operations remains a concern.In the past year, shares of this Zacks Rank #2  company have surged 16.9%, outperforming the industry’s 9.2% growth and the S&P 500 composite’s 14.5% rise.The renowned medical device company has a market capitalization of $32.87 billion. RMD has an earnings yield of 4.2%, outpacing the industry’s 1.5%. The company’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 6.86%.Robust Mask Sales: ResMed continues to see strong demand for its market-leading mask portfolio, gaining from a competitor’s recall. Continued product development is driving growth within this business globally. The company has successfully int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/worth-adding-resmed-stock-portfolio-131100726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0238689110.USD","LU1880398471.USD","LU1983299246.USD","LU2362541513.USD","LU0266013472.USD","LU0528227936.USD","LU2491049909.HKD","BSX","LU0011850046.USD","LU0128525689.USD","LU1718418525.SGD","LU2491050154.USD","LU2265009873.SGD","RMD.AU","LU2362540622.SGD","LU0889566641.SGD","BK4548","LU0077335932.USD","LU0048584097.USD","LU0162691827.USD","LU2324357040.USD","LU1791710400.SGD","BK4567","LU0114720955.EUR","LU2506951875.HKD","LU0211327993.USD","LU0072461881.USD","IE0002141913.USD","LU0122379950.USD","BK4082","LU2244417387.USD","RMD","LU0792757196.USD","LU0823416689.USD","LU1804176565.USD","LU0310800965.SGD","LU2506952170.USD","CAH","BK4504","LU2506951958.HKD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0823417737.USD","LU1571399168.USD","LU2362541273.HKD","IE0009355771.USD","LU2087625088.SGD","LU2177674079.SGD","BK4175","SG9999001440.SGD","PAHC"],"gpt_icon":0},{"id":"2517480505","title":"InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480505","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480505?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:00","pubTimestamp":1741352400,"startTime":"0","endTime":"0","summary":"JENA, Germany, March  07, 2025  (GLOBE NEWSWIRE) -- InflaRxN.V.(Nasdaq:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/07/3038913/0/en/InflaRx-Showcases-Vilobelimab-s-Role-in-Immuno-Dermatology-at-the-2025-AAD-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","BK4534","SG9999014542.SGD","LU1162221912.USD","LU1868836914.USD","SG9999014567.USD","LU0689626769.HKD","BK4139","IE00BWXC8680.SGD","PD","LU1066053197.SGD","LU1430594728.SGD","LU0234572021.USD","SG9999015358.SGD","IE00B3T34201.USD","USA","PG","BK4559","SG9999002232.USD","LU1868837136.USD","LU2129689431.USD","BK4535","LU2129689514.USD","LU0061475181.USD","LU1929549753.HKD","SG9999014575.USD","LU0094547139.USD","BNTX","BK4568","IE00BLSP4239.USD","BK4504","LU1169589451.USD","PK","SG9999002224.SGD","BK4018","LU1868837300.USD","ARDS","LU1585245621.USD","SG9999015341.SGD","BK4567","LU0868494617.USD","LU2552382215.SGD","LU1066051498.USD","BK4533","LU1868836591.USD","SG9999001440.SGD","BK4581","LU0234570918.USD","BK4558","BK4181"],"gpt_icon":0},{"id":"2517448228","title":"Vertex Pharmaceuticals' Triple Combination Cystic Fibrosis Therapy Alyftrek Receives Approval in UK","url":"https://stock-news.laohu8.com/highlight/detail?id=2517448228","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517448228?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:46","pubTimestamp":1741351613,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals' (VRTX) triple combination medicine deutivacaftor, tezacaftor,vanzacaftor was approved by the UK's Medicines and Healthcare products Regulatory Agency for treating cystic fibros","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","IE00B19Z3B42.SGD","LU2362541513.USD","IE0002270589.USD","LU1035775433.USD","LU2456880835.USD","IE00B19Z9P08.USD","LU1069344957.HKD","LU2362541273.HKD","VERX","BK4567","BK4533","LU1093756325.SGD","LU0109394709.USD","LU2324357040.USD","IE00BZ9MQY76.HKD","BK4588","LU0823416689.USD","LU2417539215.USD","LU2462157665.USD","LU1585245621.USD","LU1093756168.USD","VRTX","IE00B4R5TH58.HKD","LU0061475181.USD","LU0256863811.USD","IE00B19Z9Z06.USD","LU0234570918.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU2362540622.SGD","BK4139","IE00B19Z3581.USD","LU0417517546.SGD","LU0289739699.SGD","LU1430594728.SGD","IE00B894F039.SGD","IE0009355771.USD","LU2236285917.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0079474960.USD","BK4532","IE00B2B36J28.USD","LU0058720904.USD","LU0889565916.HKD","BK4585","LU2237438978.USD"],"gpt_icon":0},{"id":"2517484532","title":"Analysts Have Conflicting Sentiments on These Industrial Goods Companies: GFL Environmental (GFL), Joby Aviation (JOBY) and Fastenal Company (FAST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484532?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:12","pubTimestamp":1741349557,"startTime":"0","endTime":"0","summary":"Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on GFL Environmental (GFL – Research Report), J...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-industrial-goods-companies-gfl-environmental-gfl-joby-aviation-joby-and-fastenal-company-fast?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-industrial-goods-companies-gfl-environmental-gfl-joby-aviation-joby-and-fastenal-company-fast?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4567","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","JOBY","BK4104","BK4008","LU2236285917.USD","BK4585","BK4603","FAST","BK4120","BK4588","GFL","IE00BFXG0V08.USD","LU2463526074.USD","LU2211815571.USD"],"gpt_icon":0},{"id":"2517748627","title":"BRIEF-UK's MHRA Approves Triple Combination Of Deutivacaftor/Tezacaftor/Vanzacaftor For Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517748627","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517748627?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:39","pubTimestamp":1741347561,"startTime":"0","endTime":"0","summary":"BRIEF-UK's MHRA Approves Triple Combination Of Deutivacaftor/Tezacaftor/Vanzacaftor For Cystic FibrosisMarch 7 (Reuters) - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY:UK'S MHRA SAYS TRIPLE COM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU0109394709.USD","LU1093756325.SGD","LU2236285917.USD","BK4533","BK4139","LU2456880835.USD","BK4567","IE0002141913.USD","LU1093756168.USD","LU2362540622.SGD","LU1069344957.HKD","LU2462157665.USD","LU2362541513.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4585","LU1585245621.USD","LU1035775433.USD","LU2417539215.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU0058720904.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","LU2237438978.USD","LU0079474960.USD","LU2324357040.USD","BK4588","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU0320765992.SGD","VRTX","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU2362541273.HKD","IE0009355771.USD","LU0417517546.SGD","LU1430594728.SGD","LU0256863811.USD","LU0889565916.HKD","BK4532"],"gpt_icon":0},{"id":"2517486604","title":"UK's Mhra Says Triple Combination Medicine Deutivacaftor/Tezacaftor/Vanzacaftor Approved for Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517486604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517486604?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:37","pubTimestamp":1741347452,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0256863811.USD","LU1430594728.SGD","LU0889565916.HKD","LU1069344957.HKD","VRTX","LU2236285917.USD","LU2237438978.USD","IE0002141913.USD","LU2462157665.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4585","LU1585245621.USD","BK4139","LU0058720904.USD","LU0823416689.USD","IE00B19Z3581.USD","LU2362541513.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","BK4533","LU0417517546.SGD","LU2362540622.SGD","BK4567","LU1035775433.USD","IE00B2B36J28.USD","LU1093756325.SGD","LU2456880835.USD","LU0289739699.SGD","LU2417539215.USD","LU1093756168.USD","BK4532","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","LU2324357040.USD","LU0079474960.USD","BK4588","IE00BZ9MQY76.HKD","IE00B894F039.SGD","LU2362541273.HKD","IE0002270589.USD","LU0234570918.USD","LU0320765992.SGD","LU0061475181.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2517860394","title":"Exploring 3 High Growth Tech Stocks In The US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517860394","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517860394?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:08","pubTimestamp":1741345693,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has dropped 2.7%, but it has shown resilience with an 11% rise over the past year and earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these positive longer-term trends.Top 10 High Growth Tech Companies In The United States. Overview: Vertex, Inc. offers enterprise tax technology solutions for the retail trade, wholesale trade, and manufacturing industries both in the United States and internationally, with a market cap of approximately $5.39 billion.Operations: Vertex, Inc. generates revenue primarily from its Software & Programming segment, which contributes approximately $666.78 million. The company focuses on providing tax technology solutions across retail trade, wholesale trade, and manufacturing sectors globally.Unlock comprehensive insights into our analysis of Vertex stock in this hea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-3-high-growth-tech-110813721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJT1NW94.SGD","LU0566484027.USD","LU0757428866.USD","LU1069344957.HKD","LU2417539215.USD","AVXL","LU0058720904.USD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU1815336091.USD","VRTX","BK4023","LU0061475181.USD","IE00B19Z9Z06.USD","BK4567","LU1559883803.SGD","LU2236285917.USD","LU2324357040.USD","IE00B19Z9P08.USD","LU0889565916.HKD","LU2237438978.USD","LU2362541513.USD","IE00B19Z3B42.SGD","SRPT","IE00BFTCPJ56.SGD","LU1093756325.SGD","IE00B19Z3581.USD","BK4533","LU0256863811.USD","LU0079474960.USD","LU0823416689.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","BK4588","LU0234570918.USD","LU1035775433.USD","LU2456880835.USD","LU2462157665.USD","IE00B2B36J28.USD","LU0320765992.SGD","LU2362541273.HKD","LU0289739699.SGD","LU0109394709.USD","IE0002141913.USD","LU1585245621.USD","IE0009355771.USD","VERX","BK4585","LU2362540622.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2517813483","title":"It's retailers' turn to be 'resilient': Morning Brief","url":"https://stock-news.laohu8.com/highlight/detail?id=2517813483","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517813483?lang=en_us&edition=fundamental","pubTime":"2025-03-07 18:57","pubTimestamp":1741345041,"startTime":"0","endTime":"0","summary":"This is The Takeaway from today's Morning Brief, which you can sign up to receive in your inbox every morning along with:. After years of the \"resilient consumer,\" a cooling economy redefined by tariffs will test the wherewithal of American retailers.After two years of gains at Abercrombie & Fitch , the company said earlier this week that it expects slower sales growth in 2025, in part due to the impact of tariffs on freight costs and consumer spending. Wall Street pummeled the stock, along with Target, Best Buy, and others whose leaders, in diplomatic, corporate language, managed to crystalize the abstract discussion of tariffs into a warning.Best Buy  CEO Corie Barry said it's \"highly likely\" consumers will see a price impact from tariffs as around 55% of its products are sourced from China \"in some way, shape, or form.\". The retail sales report for February will be released later this month. It won't capture the full effects of the tariffs and retail uncertainty, but it could give a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/its-retailers-turn-to-be-resilient-morning-brief-105721520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1280957306.USD","BK4550","LU2125154778.USD","LU0310799852.SGD","LU0256863811.USD","LU2750360997.AUD","BK4533","LU2264538146.SGD","LU2237443382.USD","COST","IE0034235188.USD","ANF","LU0868494617.USD","BK4155","TGT","LU1244550577.SGD","LU1066051811.HKD","LU2237443622.USD","WMT","LU1035773651.USD","LU2430703178.SGD","BK4581","LU0052756011.USD","LU2430703251.USD","BK4114","LU2361045086.USD","LU0417517546.SGD","LU0265550946.USD","BJ","BK4588","BBY","LU2125154935.USD","LU1116320737.USD","LU2237443978.SGD","LU1064131342.USD","LU2237443549.SGD","LU0942090050.USD","LU0314104364.USD","LU2360032135.SGD","LU1244550494.USD","LU0149725797.USD","LU1814569148.SGD","LU1244550221.USD","LU2505996509.AUD","LU2471134879.HKD","LU2750360641.GBP","BK4567","LU0265550359.USD","BK4076","LU1585245621.USD","LU1069347547.HKD"],"gpt_icon":1},{"id":"2517177749","title":"Elia Group Announces EUR 2.2 Bln Equity Package","url":"https://stock-news.laohu8.com/highlight/detail?id=2517177749","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517177749?lang=en_us&edition=fundamental","pubTime":"2025-03-07 16:32","pubTimestamp":1741336339,"startTime":"0","endTime":"0","summary":"March 7 (Reuters) - Elia Group SA ::*ANNOUNCES EUR 2.2 BLN EQUITY PACKAGE*PACKAGE INCLUDES SECURED EUR 850 MLN VIA PRIVATE PLACEMENT*ATLAS WITH THE FUTURE FUND TO SUBSCRIBE EUR 234.6 MLN, BLACKROCK EU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nRSD9Wynl9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0731783394.SGD","BK4567","IE00B3PB1722.GBP","IE00BGHQF631.EUR","LU1988902786.USD","IE00B64PRP62.GBP","BK4588","BK4135","LU1670627923.USD","LU1670628061.USD","BK4581","LU2430703095.HKD","BLK","LU0070302665.USD","LU0320765489.SGD","LU2505996681.GBP","IE00BVYPNV92.GBP","BK4533","LU1280957306.USD","LU0742537680.HKD","LU1989771016.USD","LU1201861249.SGD","LU1064131342.USD","LU0208291251.USD","BK4504","IE00BGHQF748.EUR","IE00B42XCP33.USD","LU1074936037.SGD","BK4534","LU2505996509.AUD","LU0640476718.USD","LU1291159041.SGD","LU2264538146.SGD","LU2430703251.USD","LU0980610538.SGD","LU0648001328.SGD","LU0731783048.USD","LU1481011671.HKD","LU2430703178.SGD","IE00BDGV0183.EUR","LU0130102774.USD","LU0772969993.USD","LU2592432038.USD","IE00B3QW5Z07.USD","BK4585","IE00BVYPNW00.USD","LU1509826696.USD","BK4535","LU1481011911.USD","LU1599440770.SGD"],"gpt_icon":0},{"id":"2517917261","title":"Agilent’s Strategic Positioning in the Lp(a) Market: A Compelling Buy Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2517917261","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517917261?lang=en_us&edition=fundamental","pubTime":"2025-03-07 16:03","pubTimestamp":1741334580,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on A stock, giving a Buy rating on February 27. Roanna Ruiz’s rating is ba...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/agilents-strategic-positioning-in-the-lpa-market-a-compelling-buy-recommendation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/agilents-strategic-positioning-in-the-lpa-market-a-compelling-buy-recommendation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2092937221.SGD","IE00BN0W2V16.EUR","LU2041044095.USD","LU2413666426.HKD","BK4121","LU0347712357.USD","LU2413666699.HKD","LU1165135440.EUR","BK4585","A","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU1543694498.USD","BK4567","BK4588","LU1721428933.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":40,"pageCount":35,"totalSize":635}]}}